Search Results 1141-1150 of 2345 for 搜索引擎关键词搜索技巧咨询邮箱:lgooxc@hotmail.com
This open-label study is to determine the safety and efficacy of momelotinib in participants with either polycythemia vera (PV) or essential thrombocythemia (ET) ...
The purpose of this study is to determine the usefulness of combining PET scan activity and MRI image biomarkers for the clinical management of spinal joint low ...
About this study. The purpose of this study is to compare the progression-free survival of patients with recurrent or metastatic squamous cell carcinoma of ...
See faculty and staff of Mayo Clinic's Genome Function, Stability and Nuclear Organization in Cancer Lab led by Veronica Rodriguez-Bravo, Ph.D.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to analyze the ovary function of female premenopausal melanoma survivors who have undergone immunotherapy, and to compare with data ...
About this study. The purpose of this study is to obtain and analyze existing newborn screening data from previously identified patients with a confirmed ...
Regorafenib might or might not slow down the growth of your tumor, or shrink your tumor. Regorafenib is approved in the United States to treat colon cancer and ...
The purpose of this study is to characterize the readily available (circulating in peripheral blood) mediators of cell proliferation in individuals undergoing ...
The purpose of this study is to confirm that adding custirsen to standard first-line docetaxel and prednisone treatment can slow tumor progression in men who ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.